Design and assessment of anti-biofilm peptides: steps toward clinical application

M Dostert, CR Belanger, REW Hancock - Journal of innate immunity, 2019 - karger.com
Highly antibiotic resistant, microbial communities, referred to as biofilms, cause various life-
threatening infections in humans. At least two-thirds of all clinical infections are biofilm …
被引用次数：101 相关文章

Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application.

M Dostert, CR Belanger… - Journal of Innate …, 2019 - search.ebscohost.com
Highly antibiotic resistant, microbial communities, referred to as biofilms, cause various life-
threatening infections in humans. At least two-thirds of all clinical infections are biofilm …

Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application

M Dostert, CR Belanger, REW Hancock - Journal of Innate Immunity, 2019 - go.gale.com
Highly antibiotic resistant, microbial communities, referred to as biofilms, cause various life-
threatening infections in humans. At least two-thirds of all clinical infections are biofilm …

Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application.

M Dostert, CR Belanger, REW Hancock - Journal of Innate Immunity, 2018 - europepmc.org
Highly antibiotic resistant, microbial communities, referred to as biofilms, cause various life-
threatening infections in humans. At least two-thirds of all clinical infections are biofilm …

Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application

M Dostert, CR Belanger… - Journal of innate …, 2019 - pubmed.ncbi.nlm.nih.gov
Highly antibiotic resistant, microbial communities, referred to as biofilms, cause various life-
threatening infections in humans. At least two-thirds of all clinical infections are biofilm …

Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application

M Dostert, CR Belanger, REW Hancock - Journal of Innate Immunity, 2018 - cir.nii.ac.jp
抄録< jats: p> Highly antibiotic resistant, microbial communities, referred to as biofilms,
cause various life-threatening infections in humans. At least two-thirds of all clinical …
[PDF] ubc.ca

[PDF][PDF] Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application

MDCRB Robert, EW Hancock - 2018 - cmdr.ubc.ca
Highly antibiotic resistant, microbial communities, referred to as biofilms, cause various life-
threatening infections in humans. At least two-thirds of all clinical infections are biofilm …
[HTML] nih.gov

[HTML][HTML] Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application

M Dostert, CR Belanger… - Journal of Innate Immunity, 2019 - ncbi.nlm.nih.gov
Highly antibiotic resistant, microbial communities, referred to as biofilms, cause various life-
threatening infections in humans. At least two-thirds of all clinical infections are biofilm …
[HTML] karger.com

[HTML][HTML] Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application

M Dostert, CR Belanger, REW Hancock - Journal of Innate Immunity, 2019 - karger.com
Highly antibiotic resistant, microbial communities, referred to as biofilms, cause various life-
threatening infections in humans. At least two-thirds of all clinical infections are biofilm …

Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application

M Dostert, CR Belanger… - Journal of Innate …, 2019 - research.sahmri.org.au
Highly antibiotic resistant, microbial communities, referred to as biofilms, cause various life-
threatening infections in humans. At least two-thirds of all clinical infections are biofilm …